Combined evaluation of risk factors predicting poor ovarian responders in Chinese patients undergoing in vitro fertilization

References

• Pandian Z, McTavish AR, Aucott L, et al. Interventions for ‘poor responders' to controlled ovarian hyper stimulation (COH) in in-vitro fertilisation (IVF). Cochrane Database Syst Rev 2010;(1):CD004379. doi: 10.1002/14651858.CD004379.pub3
   PubMedGoogle Scholar
• Ubaldi FM, Rienzi L, Ferrero S, et al. Management of poor responders in IVF. Reprod Biomed Online 2005;10:235–46
   PubMed Web of Science ®Google Scholar
• IVF Worldwide Survey. Poor responders: how to define, diagnose and treat? NEWSM Letter, 8 August 2010. Available from: http://www.IVF-Worldwide.com
   Google Scholar
• Fridstrom M, Akerlof E, Sjoblom P, Hillensjo T. Serum levels of luteinizing and follicle-stimulating hormones in normal and poor-responding patients undergoing ovarian stimulation with urofollitropin after pituitary downregulation. Gynecol Endocrinol 1997;11:25–8
   PubMed Web of Science ®Google Scholar
• Raga F, Bonilla-Musoles F, Casañ EM, Bonilla F. Recombinant follicle stimulating hormone stimulation in poor responders with normal basal concentrations of follicle stimulating hormone and oestradiol: improved reproductive outcome. Hum Reprod 1999;14:1431–4
   PubMed Web of Science ®Google Scholar
• Chong AP, Rafael RW, Forte CC. Influence of weight in the induction of ovulation with human menopausal gonadotropin and human chorionic gonadotropin. Fertil Steril 1986;46:599–603
   PubMed Web of Science ®Google Scholar
• Rombauts L, Suikkari AM, MacLachlan V, et al. Recruitment of follicles by recombinant human follicle-stimulating hormone commencing in the luteal phase of the ovarian cycle. Fertil Steril 1998;69:665–9
   PubMed Web of Science ®Google Scholar
• Surrey ES, Bower J, Hill DM, et al. Clinical and endocrine effects of a microdose GnRH agonist flare regimen administered to poor responders who are undergoing in vitro fertilization. Fertil Steril 1998;69:419–24
   PubMed Web of Science ®Google Scholar
• Sallam HN, Ezzeldin F, Agameya AF, et al. The definition of ‘poor response': Bologna criteria. Hum Reprod 2012;27:626–7; author reply 627–8
   PubMed Web of Science ®Google Scholar
• Huber M, Hadziosmanovic N, Berglund L, Holte J. Using the ovarian sensitivity index to define poor, normal, and high response after controlled ovarian hyperstimulation in the long gonadotropin-releasing hormone-agonist protocol: suggestions for a new principle to solve an old problem. Fertil Steril 2013;100:1270–6
   PubMed Web of Science ®Google Scholar
• Singh N, Begum AA, Malhotra N, et al. Role of early serum beta human chorionic gonadotropin measurement in predicting multiple pregnancy and pregnancy wastage in an in vitro ET fertilization cycle. J Hum Reprod Sci 2013;6:213–18
   PubMedGoogle Scholar
• Li HW, Lee VC, Lau EY, et al. Role of baseline antral follicle count and anti-Mullerian hormone in the index stimulation cycle of IVF treatment in predicting outcome of subsequent frozen-thawed embryo transfers. Gynecol Endocrinol 2014;30:490–3
   PubMed Web of Science ®Google Scholar
• Broekmans FJ, Verweij PJ, Eijkemans MJ, et al. Prognostic models for high and low ovarian responses in controlled ovarian stimulation using a GnRH antagonist protocol. Hum Reprod 2014;29:1688–97
   PubMed Web of Science ®Google Scholar
• Brugo Olmedo S, De Vincentiis S, De Martino E, et al. Prediction of reproductive outcomes according to different serum anti-Mullerian hormone levels in females undergoing intracystoplasmic sperm injection. PLoS One 2013;8:e75685
   Web of Science ®Google Scholar
• Ryu RK, Chrisman HB, Omary RA, et al. The vascular impact of uterine artery embolization: prospective sonographic assessment of ovarian arterial circulation. J Vasc Interv Radiol 2001;12:1071–4
   PubMed Web of Science ®Google Scholar
• Cao ZY. The pathology of endometriosis. Chin Obstet Gynecol 2004;2:1486–8
   Google Scholar
• Zhen XM, Qiao J, Li R, et al. The clinical analysis of poor ovarian response in in-vitro-fertilization embryo-transfer among Chinese couples. J Assist Reprod Genet 2008;25:17–22
   PubMed Web of Science ®Google Scholar
• Younis JS. Ovarian aging: latest thoughts on assessment and management. Curr Opin Obstet Gynecol 2011;23:427–34
   PubMed Web of Science ®Google Scholar
• Lass A. Assessment of ovarian reserve – is there a role for ovarian biopsy? Hum Reprod 2001;16:1055–7
   PubMed Web of Science ®Google Scholar
• Johnson NP, Bagrie EM, Coomarasamy A, et al. Ovarian reserve tests for predicting fertility outcomes for assisted reproductive technology: the International Systematic Collaboration of Ovarian Reserve Evaluation protocol for a systematic review of ovarian reserve test accuracy. BJOG 2006;113:1472–80
   PubMed Web of Science ®Google Scholar
• Xu J, Peng XD, Han JL, Yan JM. Effect of basal Follicle-stimulating hormone levles on ovarian response in women undergoing controlled ovarian hyper-stimulation. Fudan Univ J Med Sci 2007;34:859–76
   Google Scholar
• Gougeon A. Regulation of ovarian follicular development in primates: facts and hypotheses. Endocr Rev 1996;17:121–5
   PubMed Web of Science ®Google Scholar
• Karande V, Gleicher N. A rational approach to the management of low responders in in-vitro fertilization. Hum Reprod 1999;14:1744–8
   PubMed Web of Science ®Google Scholar
• Broer SL, Mol BW, Hendriks D, Broekmans FJ. The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count. Fertil Steril 2009;91:705–14
   PubMed Web of Science ®Google Scholar
• La Marca A, Sighinolfi G, Radi D, et al. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update 2010;16:113–30
   PubMed Web of Science ®Google Scholar
• Zhuang GL. Modern assisted reproductive technique. Beijing, China: People’s Medical Publ House; 2005
   Google Scholar
• Hendriks DJ, Mol BW, Bancsi LF, et al. Antral follicle count in the prediction of poor ovarian response and pregnancy after in vitro fertilization: a meta-analysis and comparison with basal follicle-stimulating hormone level. Fertil Steril 2005;83:291–301
   PubMed Web of Science ®Google Scholar
• Hendriks DJ, Kwee J, Mol BW, et al. Ultrasonography as a tool for the prediction of outcome in IVF patients: a comparative meta-analysis of ovarian volume and antral follicle count. Fertil Steril 2007;87:764–75
   PubMed Web of Science ®Google Scholar
• Gordon K, Verweij P. Does the antral follicle count (afc) component of the Bologna Poor Responder Criteria (AF ≤ 7) predict outcome in corifollitropin alfa cycles? Fertil Steril 2013;99:S28
   Google Scholar
• Faber BM, Mayer J, Cox B, et al. Cessation of gonadotropin-releasing hormone agonist therapy combined with high-dose gonadotropin stimulation yields favorable pregnancy results in low responders. Fertil Steril 1998;69:826–30
   PubMed Web of Science ®Google Scholar